How Episurf’s Overnight Shift to Real‑Estate Is Shaking Investors
Stock‑listed medical‑device firm Episurf pivots to a SEK 10 billion real‑estate plan, boosting revenue but deepening losses—will investors survive the risky shift?
4 minutes to read
Episurf Medical AB
Episurf Medical AB Restructures and Announces Rights Issue to Focus on US Market Expansion
Episurf Medical AB announces restructuring and rights issue to reduce costs, refocus on US market, and position itself for future growth in the healthcare equipment and supplies industry.
3 minutes to read